E1bfe0c2-figure-01 (Image 1)
Diltiazem Hydrochloride Capsule, Extended Release
Product Images NDC 0228-2918
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 0228-2918). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
E1bfe0c2-figure-02 (Image 2)
360mg 90s (Image 3)
Diltiazem Hydrochloride is a medication available in the form of extended-release capsules. Each capsule contains 360mg of Diltiazem Hydrochloride, USP, which is equivalent to 330.9 mg diitiazem. This medication is for once-a-day dosage and available in a pack of 90 capsules. It is recommended to store it at 25°C (77°F), with excursions permitted to 15° t0 30°C (59° to B6°F). This medication is manufactured by Teva Pharmaceuticals USA, Inc. and dispensed in light-resistant containers as per USP guidelines. The description also includes warnings, dosage recommendations, manufacturing details, and patent information.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
